ロード中...
Have Thoracic Endografting Outcomes Improved Since FDA Approval?
OBJECTIVE: Thoracic endovascular aneurysm repair (TEVAR) is gaining acceptance since Food and Drug Administration approval in 2005. We hypothesize that, compared to open repair (OPEN), mortality and complication rate after TEVAR have continued to improve. METHODS: All patients who underwent thoracic...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086831/ https://ncbi.nlm.nih.gov/pubmed/21439547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2011.01.037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|